SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-21-140384
Filing Date
2021-04-29
Accepted
2021-04-29 16:06:55
Documents
6
Period of Report
2021-06-10

Document Format Files

Seq Description Document Type Size
1 DEF 14A d178880ddef14a.htm DEF 14A 678411
2 GRAPHIC g178880dsp002.jpg GRAPHIC 100246
3 GRAPHIC g178880dsp003.jpg GRAPHIC 118852
4 GRAPHIC g178880g00u26.jpg GRAPHIC 29827
5 GRAPHIC g178880g26g90.jpg GRAPHIC 70446
6 GRAPHIC g178880g26w10.jpg GRAPHIC 69790
  Complete submission text file 0001193125-21-140384.txt   1212875
Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Filer) CIK: 0001597553 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36544 | Film No.: 21870518
SIC: 2834 Pharmaceutical Preparations